Mutation of the AML1/RUNX1 gene in a transient myeloproliferative disorder patient with Down syndrome
- 30 August 2002
- journal article
- Published by Springer Nature in Leukemia
- Vol. 16 (9) , 1866-1867
- https://doi.org/10.1038/sj.leu.2402612
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- A novel CBFA2 single-nucleotide mutation in familial platelet disorder with propensity to develop myeloid malignanciesBlood, 2001
- Mutations of the transcription factor AML1/CBA2 are uncommon in blastic transformation of chronic myeloid leukaemiaLeukemia, 2001
- Mutations of the AML1 gene in myelodysplastic syndrome and their functional implications in leukemogenesisBlood, 2000
- High incidence of biallelic point mutations in the Runt domain of the AML1/PEBP2αB gene in Mo acute myeloid leukemia and in myeloid malignancies with acquired trisomy 21Blood, 2000
- The Management of Neoplastic Disorders of Haematopoeisis in Children with Down's SyndromeBritish Journal of Haematology, 2000
- Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemiaNature Genetics, 1999
- Biallelic and Heterozygous Point Mutations in the Runt Domain of theAML1/PEBP2B Gene Associated With Myeloblastic LeukemiasBlood, 1999
- Cytogenetic findings and clinical features in acute leukemia and transient myeloproliferative disorder in Down's syndromeBlood, 1988